在FDA不良事件报告系统 (FAERS) 中报告的过敏反应事件的描述性分析
1Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
Journal of public health research
|March 5, 2026
概括
药物诱导的过敏反应越来越令人担忧,抗生素,止痛药和无线电对比介质是常见的罪祸首. 这项研究强调了加强药物监测的必要性,以提高患者在管理这些严重反应中的安全性.
科学领域:
- 药物监督 药物监督 药物监督
- 药品安全 药品安全
- 临床研究 临床研究
背景情况:
- 过敏反应是一种严重的过敏反应,呈现出日益严重的全球健康挑战.
- 药物是成人过敏反应的主要触发因素,但全面的真实世界数据仍然很少.
- 了解药物特定的过敏反应模式对于公共卫生至关重要.
研究的目的:
- 使用FDA不良事件报告系统 (FAERS) 数据库系统地识别药物诱导的过敏反应病例.
- 量化与药物诱导的过敏反应相关的结果.
- 为了确定最常与过敏反应相关的特定药物.
主要方法:
- 一个回顾性药监测研究,利用FAERS数据从开始到2025年9月.
- 使用首选术语识别过敏症病例.
- 对患者人口统计,报告员类型,结果和可疑药物的描述性分析.
主要成果:
- 对98,081例病例的分析显示,死亡率为5.53%,大多数病例严重但非致命 (91.10%).
- 抗生素 (25%),止痛药 (20%) 和无线电对比介质 (15%) 是最常见的药物类别.
- 确定奥马利祖马布,普罗波和因弗利克西马布是与过敏反应相关的顶级个人药物.
结论:
- 药物诱导的过敏反应代表着一个显著的和日益增加的公共卫生负担.
- 调查结果强调了临床医生持续警和强大的药物监测系统的重要性.
- 加强监测对于改善患者安全和减轻过敏反应风险至关重要.
相关概念视频
Allergic Reactions: Anaphylaxis
92
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
92
Allergic Reactions
33.1K
Overview
33.1K
Antibody Structure
66.6K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
66.6K
Allergic Drug Reactions
1.5K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.5K
Pharmacovigilance
1.9K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K
Drug Toxicity: Allergic Reactions
75
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
75


